MVA is the vaccine currently used and stockpiled in the United States Strategic National Stockpile for immunization against potential bioterrorism threats based on the smallpox virus. Development ...
LAURIE GARRETT is a science journalist and writer. For her reporting on epidemics and other public health crises, she has received a Peabody Award, a George Polk Award, and a Pulitzer Prize for ...
Advances in biological research likely will permit development of a new class of advanced biological warfare (ABW) agents engineered to elicit novel effects. In addition, biotechnology will have ...
The Frederick biotechnology company BioFactura has announced $7.8 million in new contract activations to study a treatment for a potential smallpox outbreak. The company has gotten contract option ...